bmy 25067 has been researched along with Urinary Bladder Neoplasms in 5 studies
*Urinary Bladder Neoplasms: Tumors or cancer of the URINARY BLADDER. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emerson, EO; Gupta, V; Jani, JP; Singh, SV; Xu, BH; Zaren, HA | 1 |
| Gupta, V; Singh, SV; Xu, BH | 1 |
| Benson, PJ; Gupta, V; Hu, X; Pinto, T; Singh, S; Xia, H; Zaren, HA | 1 |
| Au, JL; Yen, WC | 1 |
| Bleicher, RJ; Gupta, V; Hu, X; Singh, SV; Srivastava, SK; Xia, H; Zaren, HA | 1 |
5 other study(ies) available for bmy 25067 and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Characterization of a human bladder cancer cell line selected for resistance to BMY 25067, a novel analogue of mitomycin C.
Topics: Antineoplastic Agents; Cell Cycle; Drug Resistance; Glutathione; Glutathione Transferase; Humans; In Vitro Techniques; Mitomycin; Mitomycins; NAD(P)H Dehydrogenase (Quinone); NADPH-Ferrihemoprotein Reductase; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1995 |
Mechanism of differential sensitivity of human bladder cancer cells to mitomycin C and its analogue.
Topics: DNA, Neoplasm; Drug Resistance; Humans; Lipid Peroxidation; Mitomycin; Mitomycins; Tumor Cells, Cultured; Tumor Stem Cell Assay; Urinary Bladder Neoplasms | 1994 |
Lack of a role of glutathione in cellular nonenzymatic activation of BMS-181174, a novel analogue of mitomycin C.
Topics: Antineoplastic Agents, Alkylating; Biotransformation; Buthionine Sulfoximine; Cysteine; Enzyme Inhibitors; Glutamate-Cysteine Ligase; Glutathione; Humans; Methionine Sulfoximine; Mitomycin; Mitomycins; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1996 |
Pharmacodynamic evaluation of mitomycin C analog BMS-181174 for potential use in intravesical bladder cancer therapy.
Topics: Administration, Intravesical; Antineoplastic Agents, Alkylating; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cell Survival; Mitomycin; Mitomycins; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1997 |
Characterization of a BMS-181174-resistant human bladder cancer cell line.
Topics: Antineoplastic Agents, Alkylating; Cell Survival; Drug Resistance; Humans; Mitomycin; Mitomycins; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1997 |